Search Browse Earnings

60 DEGREES PHARMACEUTICALS, INC. — SlamSEC

60 DEGREES PHARMACEUTICALS, INC.

Nasdaq:SXTPNasdaq:SXTPW

Pharmaceutical Preparations·WASHINGTON, DC

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Dow Geoffrey S

Revenue

$253,573

+13.6% YoY

FY 2024

Adj. EBITDA

-$5.1M

-2024.4% margin

FY 2024

Net Income

-$3.8M

-1485.1% margin

FY 2024

EPS (Diluted)

-$59.18

FY 2024

Stock Price

$1.89

-0.3%

2026-03-10

52W Range

$1.36 – $17.68

P/E Ratio

-0.0x

Market Cap

$8.0M

Cash

$2.1M

FY 2024

Total Debt

$3.1M

FY 2024

Net Debt

$1.0M

FY 2024

Enterprise Value

$9.0M

Debt / EBITDA

-0.2x

FY 2024

EV / EBITDA

-1.7x

Employees

—